Predictive factors for survival in borderline resectable and locally advanced pancreatic cancer: are these really two different entities?

Abstract Background The treatment of borderline resectable (BR) and locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC) has evolved with a wider application of neoadjuvant chemotherapy (NACHT). The aim of this study was to identify predictive factors for survival in BR and LA PDAC. Methods...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Luís Filipe Abreu de Carvalho, Filip Gryspeerdt, Niki Rashidian, Kobe Van Hove, Lambertine Maertens, Suzane Ribeiro, Anne Hoorens, Frederik Berrevoet
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2023-09-01
Colecção:	BMC Surgery
Assuntos:	Pancreatic cancer Borderline resectable pancreatic cancer Locally advanced pancreatic cancer Neoadjuvant chemotherapy FOLFIRINOX
Acesso em linha:	https://doi.org/10.1186/s12893-023-02200-6
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!